vTv Therapeutics (VTVT) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

VTVT is expected to report earnings to fall 12.50% to -7 cents per share on February 28

vTv Therapeutics VTVT Stock Earnings Reports

Q4'23

Est.

$-0.07

Q3'23

Est.

$-0.08

Q2'23

Missed

by $2.73

Q1'23

Beat

by $0.05

Q4'22

Missed

by $2.34

The last earnings report on November 09 showed earnings per share of -7 cents, meeting the estimate of -7 cents. With 13.77K shares outstanding, the current market capitalization sits at 31.94M.

View a ticker or compare two or three

Compare

VTVT

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For VTVT
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a clinical-stage pharmaceutical holding company, which focuses on the discovery and development of human therapeutics

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

3980 Premier Drive

Phone

+1 336 841-0300

Employees

Web

https://www.vtvtherapeutics.com